Deprince Race & Zollo Inc. Acquires 48,580 Shares of Elevance Health, Inc. $ELV

Key Points

• Deprince Race & Zollo Inc. increased its stake in Elevance by 75.9%, buying 48,580 shares in Q4 to own 112,600 shares worth $39.47 million (about 0.05% of the company).
• Elevance reported Q4 EPS of $3.33 (beating the $3.10 estimate) with revenue of $49.31 billion (a slight miss) and 9.6% year-over-year revenue growth, and the company set FY2026 EPS guidance around 25.5.
• Elevance raised its quarterly dividend to $1.72 (annualized $6.88, yield 2.2%), while analysts' consensus is a "Hold" with an average price target of $385.38.

Deprince Race & Zollo Inc. grew its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 75.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 112,600 shares of the company's stock after purchasing an additional 48,580 shares during the quarter. Deprince Race & Zollo Inc. owned approximately 0.05% of Elevance Health worth $39,472,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the company. U.S. Capital Wealth Advisors LLC raised its stake in shares of Elevance Health by 50.7% during the 4th quarter. U.S. Capital Wealth Advisors LLC now owns 2,113 shares of the company's stock worth $741,000 after acquiring an additional 711 shares in the last quarter. Choreo LLC raised its stake in shares of Elevance Health by 25.5% during the 4th quarter. Choreo LLC now owns 5,452 shares of the company's stock worth $1,902,000 after acquiring an additional 1,107 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Elevance Health by 0.6% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 949,000 shares of the company's stock worth $332,672,000 after acquiring an additional 5,933 shares in the last quarter. Clear Creek Financial Management LLC raised its stake in shares of Elevance Health by 26.1% during the 4th quarter. Clear Creek Financial Management LLC now owns 1,586 shares of the company's stock worth $556,000 after acquiring an additional 328 shares in the last quarter. Finally, Howard Capital Management Inc. raised its stake in shares of Elevance Health by 129.1% during the 4th quarter. Howard Capital Management Inc. now owns 4,727 shares of the company's stock worth $1,657,000 after acquiring an additional 2,664 shares in the last quarter. Institutional investors own 89.24% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ELV. Jefferies Financial Group dropped their target price on shares of Elevance Health from $401.00 to $395.00 and set a "buy" rating on the stock in a research report on Friday, January 30th. Leerink Partners boosted their target price on shares of Elevance Health from $350.00 to $357.00 and gave the stock a "market perform" rating in a research report on Thursday, January 29th. Royal Bank Of Canada downgraded shares of Elevance Health from an "outperform" rating to a "sector perform" rating and set a $358.00 target price on the stock. in a research report on Tuesday, February 3rd. Wall Street Zen downgraded shares of Elevance Health from a "buy" rating to a "hold" rating in a research report on Sunday, February 8th. Finally, Morgan Stanley dropped their target price on shares of Elevance Health from $359.00 to $352.00 and set an "equal weight" rating on the stock in a research report on Wednesday, December 17th. Twelve research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Elevance Health currently has an average rating of "Hold" and a consensus price target of $385.38.

Elevance Health Stock Up 0.0%

ELV stock opened at $311.54 on Monday. The firm's fifty day simple moving average is $311.25 and its 200-day simple moving average is $332.13. The company has a market capitalization of $68.43 billion, a P/E ratio of 12.40, a price-to-earnings-growth ratio of 1.71 and a beta of 0.49. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.54 and a quick ratio of 1.54. Elevance Health, Inc. has a 12 month low of $273.71 and a 12 month high of $443.29.

Elevance Health (NYSE:ELV - Get Free Report) last announced its quarterly earnings results on Wednesday, January 28th. The company reported $3.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.10 by $0.23. Elevance Health had a net margin of 2.84% and a return on equity of 15.59%. The firm had revenue of $49.31 billion for the quarter, compared to the consensus estimate of $49.52 billion. During the same period in the prior year, the firm posted $3.84 earnings per share. The firm's quarterly revenue was up 9.6% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 25.500- EPS. As a group, equities research analysts forecast that Elevance Health, Inc. will post 33.96 earnings per share for the current year.

Elevance Health Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 25th. Investors of record on Tuesday, March 10th were issued a dividend of $1.72 per share. This represents a $6.88 dividend on an annualized basis and a yield of 2.2%. This is a boost from Elevance Health's previous quarterly dividend of $1.71. The ex-dividend date of this dividend was Tuesday, March 10th. Elevance Health's payout ratio is currently 27.39%.

Elevance Health Profile

Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.

Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.